Incoming Rx Intern Industry Slowdown Concerns

Hi all,

I'm an incoming Rx Consulting intern at a Big 3 Rx firm (FTI/A&M/AlixPartners) as a junior in undergrad. I'm very, very fortunate to have this opportunity but can't help and think about full-time conversion returns. 

I'm sure over the last year or so, hiring for restructuring/turnaround was very necessary and so more likely than not many firms began increasing recruiting. Now, based off Rx slowdown, it seems that there is a lot of pitching and not a ton of work to be done (or as much as last year). Should this be something to concern myself with?

It would be nice to see how people think this'll impact full-time. Does anyone have any advice for this situation? Would it be recommended to begin/continue networking with individuals in the Rx space (i.e. speak to Rx IBs, other Rx consulting firms, even something like McKinsey RTS, BCG TURN, e.t.c.)?

Really appreciate all the help and insight! 

*Posting this in both consulting and IB in case Rx bankers and others have suggestions

 

I work in Rx/distressed space - wouldn't be concerned. If anything, they will extend less 3rd year offers in the future to make room for your class (not sure if this is the same in consulting). Given the SPAC boom, there's still a lot of work expected around the corner, even if it's requiring a bit more creativity these days. I'd still recommend pursuing Rx if it's of interest to you. When cycles turn, it's a lot easier to go from Rx to M&A than the other way around. 

That being said, I am seeing some headcount reductions at some distressed buyside shops, and some others having to flex mandates to deploy capital; however, you're still a ways off and wouldn't worry about that. Good luck!

 

Accusantium neque labore ipsa accusamus voluptatum ut. Inventore placeat ea sint doloremque et ut. Optio ullam sunt tenetur eius. Saepe placeat inventore quia.

Accusamus qui accusamus vel adipisci. Quia consectetur autem vel porro sunt asperiores cum.

Reiciendis cum officia inventore officia perspiciatis aut. Enim delectus perferendis ut animi error. Et ea quisquam est illum blanditiis voluptas ipsum unde. Quaerat inventore hic debitis perferendis quia aut modi. Occaecati eaque dolor eaque deserunt qui culpa vel.

Career Advancement Opportunities

May 2024 Investment Banking

  • Jefferies & Company 02 99.4%
  • Goldman Sachs 19 98.8%
  • Harris Williams & Co. New 98.3%
  • Lazard Freres 02 97.7%
  • JPMorgan Chase 04 97.1%

Overall Employee Satisfaction

May 2024 Investment Banking

  • Harris Williams & Co. 18 99.4%
  • JPMorgan Chase 10 98.8%
  • Lazard Freres 05 98.3%
  • Morgan Stanley 07 97.7%
  • William Blair 03 97.1%

Professional Growth Opportunities

May 2024 Investment Banking

  • Lazard Freres 01 99.4%
  • Jefferies & Company 02 98.8%
  • Goldman Sachs 17 98.3%
  • Moelis & Company 07 97.7%
  • JPMorgan Chase 05 97.1%

Total Avg Compensation

May 2024 Investment Banking

  • Director/MD (5) $648
  • Vice President (19) $385
  • Associates (88) $260
  • 3rd+ Year Analyst (14) $181
  • Intern/Summer Associate (33) $170
  • 2nd Year Analyst (67) $168
  • 1st Year Analyst (205) $159
  • Intern/Summer Analyst (146) $101
notes
16 IB Interviews Notes

“... there’s no excuse to not take advantage of the resources out there available to you. Best value for your $ are the...”

Leaderboard

1
redever's picture
redever
99.2
2
BankonBanking's picture
BankonBanking
99.0
3
Secyh62's picture
Secyh62
99.0
4
Betsy Massar's picture
Betsy Massar
99.0
5
dosk17's picture
dosk17
98.9
6
GameTheory's picture
GameTheory
98.9
7
kanon's picture
kanon
98.9
8
CompBanker's picture
CompBanker
98.9
9
Linda Abraham's picture
Linda Abraham
98.8
10
numi's picture
numi
98.8
success
From 10 rejections to 1 dream investment banking internship

“... I believe it was the single biggest reason why I ended up with an offer...”